Improving Information Flow with LegalKEY Practice Support Solutions
One of the oldest full-service national law firms in the United States, Drinker Biddle & Reath LLP, has now installed one of the newest conflict management systems available. With the addition of several new offices over the past few years, the firm has grown to more than 425 lawyers in 10 locations with further growth on the horizon. <br>In order to deal with the rapid growth of the firm, it was necessary for us to implement a system that would meet our future needs, maintain and improve the functionality of the firm, as well as fulfill all of our requirements. After researching the market, we chose Hummingbird's LegalKEY Practice Support Solutions, including LegalKEY Records Manage-ment and LegalKEY Conflicts Management. The conversion to LegalKEY combined disparate records sources into a single database, allowing the firm to work as one entity with synchronized firm-wide records management, paper and digital retention policies and a streamlined conflicts management system.
Features
Auto-Coding Comes of Age in Electronic Discovery
The challenge for Holmes Roberts & Owen was daunting: How to respond to 35 boxes of paper, a maxed-out litigation support staff, and a 7-day SEC deadline? Previously, the volume as well as the tight timeline would have made this a hopeless task. Fortunately, auto-coding offered a viable solution.
Features
Simplifying the TIFF Process
TIFFs have been the widely accepted format for electronic discovery (ED) production for more than 20 years due to their ease of use and relative simplicity in disseminating information quickly and effectively. Many programs use the .tif tags to accept or ignore fields, depending on the application. And, it is possible to lock out entire fields of metadata based on the settings for the TIFF image. So why is the TIFF production process so prone to mistakes? And, how can it be simplified?
Implementing Matter-Centric Architectures In Document Management Systems
This is the second part of a two-part series covering issues related to migrating from traditional document management systems to Matter-Centric Content Management Architectures. The first part reviewed some of the differences between these systems. This second part addresses issues involved in migration to a Matter-Centric Architecture, and Best Practices for addressing these issues.
Seiko's Smart Label Printers Bring Your Firm to the Future!
At some point or another in the life of your law firm one of your staff is going to ask the ill-fated question: "Why can't we just print one label to send this material out?" For years computer literate law firms have still had to either have pre-printed labels made with handwritten addresses or, alternatively, print an entire sheet of labels for only one address! <br>If this all too familiar scenario seems to be on your list of "been there, done thats," then it's about time that you heard the good news, and that's as easy as the words ' Seiko Smart Label Printer 430! Now you can print as many labels as you need from one at a time to many others all from within your computer.
Debate on DTC Advertising Heats Up!
Introduction to this Special Issue: This past June, the American Medical Association (AMA) joined myriad other consumer and medical interest groups to ask the question whether direct-to-consumer (DTC) advertising by pharmaceutical companies had gotten out of hand. Sensing the way the winds were blowing, the pharmaceutical industry's trade group PhRMA (Pharmaceutical and Research Manufacturers of America) announced on Aug. 2 that it would self-police DTC drug advertising practices by signing up pharmaceutical manufacturers to a voluntary agreement to follow PhRMA's new DTC policies. In this issue, we will look at those policies and at the reactions they caused in the medical, legislative and consumer communities.
New PhRMA Policy: Not Everyone Satisfied
When the Pharmaceutical and Research Manufacturers of America (PhRMA) announced it was instituting a new policy on direct-to-consumer advertising, PhRMA President and CEO Billy Tauzin stated, "With these principles, we commit ourselves to improving the inherent educational value of advertisements. Patients need accurate and timely information and should be encouraged to discuss diseases and treatment options with their physicians. These principles will help us reach that goal."
Features
PhRMA's New Rules on DTC Advertising
In response to continued scrutiny from the public and from legislators concerned over the effects of direct-to-consumer (DTC) advertising, the Board of Directors of the Pharmaceutical Research and Manufacturers Association (PhRMA) voted this past July 29 to institute what it calls a set of "Guiding Principles" that will extend and augment the current FDA rules for DTC advertisement. These principles will go into effect in January 2006.
Perez v. Wyeth and Direct-to-Consumer Ads
Six years ago, in <i>Perez v. Wyeth Laboratories Inc.</i>, 161 N.J. 1 (1999), the New Jersey Supreme Court enunciated a novel exception to the learned intermediary doctrine intended to address the rise of direct-to-consumer (DTC) marketing of prescription pharmaceuticals. The learned intermediary doctrine is a common law principle, codified in many states, that shields prescription pharmaceutical manufacturers from liability for failing to warn consumers of the potential side-effects associated with their products as long as they have adequately warned prescribing physicians. The <i>Perez</i> court, however, held that when pharmaceutical companies employ DTC advertising, there is an additional duty to warn consumers of potential risks.
Domestic Violence: Family Law Attorneys Can Get Caught in the Crossfire
Domestic violence probably impacts at least a few, if not several, of the clients you assist each year. In this Special Issue, we focus on some of the problems endemic to domestic violence: the plight of the victim when police protection is inadequate; the consequences to the perpetrator when Family Court issues impact on Criminal Court proceedings, and vice versa; and what can happen to attorneys who get swept up in their clients' problems to become potential victims of violence themselves.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Surveys in Patent Infringement Litigation: The Next FrontierMost experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- In the SpotlightOn May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug & Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.Read More ›
